P591: Anti-TNF therapy for Ulcerative Colitis in Brazil: a comparative real-world national multicentric study from the Brazilian Study Group of IBD (GEDIIB).ECCO'21 VirtualYear: 2021
Authors: Sassaki, L.Y.(1);Magro, D.O.(2);Saad-Hossne, R.(3);Baima, J.P.(1);Flores, C.(4);Correia, L.P.D.M.P.(5);Ferrari, M.D.L.D.A.(6);Zacharias, P.(7);Feitosa, M.R.(8);Santos, C.H.M.(9);Lins Neto, M.A.D.F.(10);Quaresma, A.B.(11);Lima Junior, S.F.(12);Vasconcelos, G.B.S.(13);Cassol, O.(14);Pinto, A.D.S.(15);Kurachi, G.(16);Goncalves Filho, F.D.A.(17);Gasparini, R.G.(18);Furlan, T.K.(19);Catapani, W.(20);Coy, C.S.R.(2);Menegassi, V.D.S.(21);Colombo, M.M.(22);Froes, R.D.S.B.(23);Teixeira, F.V.(3);Moraes , A.C.(24);Santana , G.O.(25);Parente, J.M.L.(26);Vilela , E.G.(27);Kotze , P.G.(7);
(1)São Paulo State University Unesp- Medical School, Department of Internal Medicine, Botucatu, Brazil;(2)University of Campinas UNICAMP, Colorectal Surgery Unit, Campinas, Brazil;(3)São Paulo State University Unesp- Medical School, Department of Surgery, Botucatu, Brazil;(4)Hospital de Clínicas de Porto Alegre, Serviço de Gastroenterologia e Hepatologia, Porto Alegre, Brazil;(5)Hospital Universitário Onofre Lopes- Universidade Federal do Rio Grande do Norte, Gastroenterology, Natal, Brazil;(6)Medical School- Universidade Federal de Minas Gerais, Department of Clinical Medicine, Belo Horizonte, Brazil;(7)Catholic University or Paraná PUCPR, IBD outpatient Clinics- Colorectal Surgery Unit, Curitiba, Brazil;(8)Ribeirao Preto Medical School- University of Sao Paulo, Department of Surgery and Anatomy, Ribeirao Preto, Brazil;(9)Universidade Federal de Mato Grosso do Sul, Surgery Department, Campo Grande, Brazil;(10)Hospital Universitário Professor Alberto Antunes HUPAA, Service of Coloproctology, Maceió, Brazil;(11)West Santa Catarina State University UNOESC, Surgery, Joaçaba, Brazil;(12)Hospital Universitário João de Barros Barreto - UFPA, Surgery, Belém, Brazil;(13)Fundacao Universidade de Pernambuco, Gastroenterologia, Recife, Brazil;(14)Hospital de Clínicas de Passo Fundo, Surgery, Passo Fundo, Brazil;(15)Fundação Universidade do Amazonas, Gastroentorology, Manaus, Brazil;(16)Gastroclinica Cascavel, Gastroenterology, Cascavel, Brazil;(17)Faculdade Regional de Medicina de São José do Rio Preto, Surgery, São José do Rio Preto, Brazil;(18)Sete centro de especialidades médicas, Surgery, Marilia, Brazil;(19)Hospital de Clínicas da Universidade Federal do Paraná - HCUFPR, Gastroenterology, Curitiba, Brazil;(20)Faculdade de Medicina do ABC, Gastroenterology, Santo Andre, Brazil;(21)Universidade Federal de Santa Catarina, Gastroenterology, Florianópolis, Brazil;(22)Hospital Doutor Dório Silva, Gastroenterology, Serra, Brazil;(23)Gastromed, Gastroenterology, Rio de Janeiro, Brazil;(24)Hospital Copa D'Or - Rede D'Or São Luiz, Gastroenterology, Rio de Janeiro, Brazil;(25)Federal University of Bahia, IBD Unit, Salvador, Brazil;(26)Hospital Universitário da Universidade Federal do Piauí HU-UFPI, Gastroenterologia, Teresina, Brazil;(27)Clinical Hospital of the Federal University of Minas Gerais, Gastroenterology, Belo Horizonte, Brazil
P592: Costs savings associated with ferric maltol and the reduced use of intravenous iron based on real world dataECCO'21 VirtualYear: 2021
Authors: Howaldt, S.(1,2,3);Becker, C.K.(4);Becker, J.A.(4);Poinas , A.C.(5);
(1)Hamburgisches Forschungsinstitut für chronisch entzündliche Darmerkrankungen- HaFCED e.K., Hamburgisches Forschungsinstitut für chronisch entzündliche Darmerkrankungen- HaFCED e.K., Hamburg, Germany;(2)ImmunoRegister Gug, ImmunoRegister Gug, Hamburg, Germany;(3)Medizinisches Versorgungszentrum für Immunologie, Medizinisches Versorgungszentrum für Immunologie, Hamburg, Germany;(4)Hamburgisches Forschungsinstitut für chronisch entzündliche Darmerkrankungen- HaFCED e.K., Medical department, Hamburg, Germany;(5)Norgine Ltd, Global Market Access & Public Affairs, Harefield, United Kingdom
P594: Utilisation of anti-TNF agents in phlegmonous Crohn’s disease: an Australian tertiary referral centre experienceECCO'21 VirtualYear: 2021
Authors: Chiu, L.(1);Digby-Bell, J.(2);Seah, J.(1,3);Melton, S.(1,4);Taylor, K.(1,2);Sparrow, M.(1,2);
(1)Monash University, Faculty of Medicine- Nursing and Health Sciences, Melbourne, Australia;(2)Alfred Health, Department of Gastroenterology, Melbourne, Australia;(3)Alfred Health, Department of Radiology, Melbourne, Australia;(4)Alfred Health, Nutrition Department, Melbourne, Australia
P595: Finding predictors of azathioprine-induced pancreatitis in patients with inflammatory bowel diseaseECCO'21 VirtualYear: 2021
Authors: Freitas, M.(1,2,3);Capela, T.(1,2,3);Macedo Silva, V.(1,2,3);Arieira, C.(1,2,3);Cúrdia Gonçalves, T.(1,2,3);Dias de Castro, F.(1,2,3);Moreira, M.J.(1,2,3);Cotter, J.(1,2,3);
(1)Hospital da Senhora da Oliveira, Gastroenterology Department, Guimarães, Portugal;(2)Life and Health Sciences Research Institute ICVS, School of Medicine- University of Minho, Braga, Portugal;(3)ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
P597: Cycling Anti-TNF Therapy in Inflammatory Bowel Disease: Effectiveness and Durability of Switching from adalimumab to infliximabECCO'21 VirtualYear: 2021
Authors: Steinberg, J.(1);Andersen, M.(1);Krugliak Cleveland, N.(1);Traboulsi, C.(1);Rodriguez, T.(1);Cohen, R.(1);Dalal, S.(1);Micic, D.(1);Pekow, J.(1);Atsushi, S.(1);Rubin, D.(1);
(1)University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States
P599: Perspectives on disease- and treatment-related issues encountered by patients with Inflammatory Bowel Disease: a qualitative concept mapping studyECCO'21 VirtualYear: 2021
Authors: Risager Christensen, K.(1);Steenholdt, C.(1);Skougaard, M.(2);Ainsworth, M.A.(3);Brynskov, J.(1);Buhl, S.(1);Kristensen, L.E.(2);Schjødt Jørgensen, T.(2);
(1)Gentofte and Herlev Hospital, Gastroenterology, Herlev, Denmark;(2)The Parker Institute- Copenhagen University Hospital, Rheumatology, Copenhagen, Denmark;(3)Odense University Hospital, Gastroenterology, Odense, Denmark
P600: Real-world clinical characteristics and therapeutic strategies in patients with moderate-to-severe Inflammatory Bowel Disease in Argentina: Data from the RISE AR studyECCO'21 VirtualYear: 2021
Authors: Lasa, J.S.(1,2);Sambuelli, A.(3);Zubiaurre, I.(2);Correa, G.J.(4);Lubrano, P.(5);Balderramo, D.C.(6,7);Ruffinengo, O.(8);Brion, L.(9);Leonardi, D.B.(9);El-Hakeh, J.(9);Guimaraens, P.N.(9);Olivera Sendra, P.(1,5);
(1)Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno CEMIC, Gastroenterology Section- Department of Internal Medicine, Buenos Aires, Argentina;(2)Hospital Británico de Buenos Aires, Gastroenterology Department, Buenos Aires, Argentina;(3)Hospital de Gastroenterología Dr. Bonorino Udaondo, Inflammatory Diseases Section, Buenos Aires, Argentina;(4)Hospital Interzonal General de Agudos General José de San Martin, Gastroenterology Department, La Plata, Argentina;(5)Sanatorio Mater Dei, Gastroenterology Department, Buenos Aires, Argentina;(6)Hospital Privado Centro Médico de Córdoba, Gastroenterology Department, Córdoba, Argentina;(7)Instituto Universitario de Ciencias Biomédicas de Córdoba, Internal Medicine Department, Córdoba, Argentina;(8)Hospital Provincial del Centenario, Gastroenterology and Hepatology Service, Rosario, Argentina;(9)Takeda Pharma S.A., Medical Affairs, Buenos Aires, Argentina
P602: Vedolizumab subcutaneous influencing disease course in Constant-care app solutionECCO'21 VirtualYear: 2021
Authors: Nørgaard, J.(1);Malte, R.(1);Charlotte, P.L.(1);Mette, B.(1);Eva, F.(1);Petra, W.(1);Dorit, A.(1);Lotte, S.(1);Johan, B.(1);Pia, M.(1);
(1)Northern Zealand Hospital, Gastroenterological department, Frederikssund, Denmark
P603: Patient characteristics and adverse effects in biologic treatment of Crohn’s Disease and Ulcerative Colitis: A nationwide Danish cohort study years 2015-2018.ECCO'21 VirtualYear: 2021
Authors: Bjørn Jensen, C.(1);Jarlov Jensen, K.(1);Wennerström, C.(2);Sommer, K.J.(3);Burisch, J.(4);Petersen, J.(1);
(1)Frederiksberg Hospital- Frederiksberg- Denmark., Copenhagen Phase IV Unit- Center for Clinical Research and Prevention-, Frederiksberg, Denmark;(2)Janssen Cilag AB, Nordic Medical Operations, Solna, Sweden;(3)Janssen-Cilag A/S, Medical Affairs, Birkerød, Denmark;(4)Hvidovre Hospital, Gastrounit- Medical Division-, Hvidovre, Denmark
P604: Evaluation of management heterogeneity and complications of Crohn’s disease in Catalonia. A population quality care studyECCO'21 VirtualYear: 2021
Authors: Brunet, E.(1);Melcarne, L.(1);Llovet, L.(1);Vela, E.(2);Cleries, M.(2);Pontes, C.(3,4);Garcia-Iglesias, P.(1,5);Albert, V.(1,5,6);Calvet, X.(1,5,6);
(1)Hospital Parc Taulí, Aparell digestiu, Sabadell, Spain;(2)Generalitat de Catalunya, Unitat d’Informació i Coneixement. Servei Català de la Salut, Barcelona, Spain;(3)Generalitat de Catalunya, Àrea del Medicament. Servei Català de la Salut, Barcelona, Spain;(4)Universitat Autònoma de Barcelona., Departament de Farmacologia- de terapéutica i de Toxicologia., Bellaterra, Spain;(5)Instituto de Salud Carlos III., CIBERehd, Madrid, Spain;(6)Universitat Autònoma de Barcelona, Departament de Medicina, Barcelona, Spain
P605: Development and validation of an objective disability index for Inflammatory Bowel Disease patients (ODIBD)ECCO'21 VirtualYear: 2021
Authors: Melcarne, L.(1);Vergara Gómez, M.(1);Villoria Ferrer, A.(1);Brunet Mas, E.(1);Garcìa Iglesias, P.(1);Llovet Soto, L.(1);Dosal Galguera, A.(1);Monllor Nunell, T.(1);Alforcea Alcaraz, S.(1);Calvet Calvo, X.(1);
(1)Hospital Universitari Parc Taulì, Digestive Disease, Sabadell Barcelona, Spain
P606: Adherence to endoscopic surveillance guidelines for advanced lesions and colorectal cancer in Inflammatory Bowel Disease in Spain: a collaborative study of AEG and GETECCU.ECCO'21 VirtualYear: 2021
Authors: Ballester Ferré, M.P.(1);Mesonero, F.(2);Flórez-Diez, P.(3);Gómez, C.(1);Fuentes-Valenzuela, E.(4);Martín, N.(5);Senosiain, C.(2);Vela, M.(6);Fernández-Clotet, A.(7);Pérez, P.(8);Rubín de Célix, C.(9);Calviño-Suárez, C.(10);Ferreiro-Iglesias, R.(10);Hermida, B.(11);Muñoz, R.(12);González-Vivo, M.(13);Brunet, E.(14); Jiménez, N.(15);Botella, B.(16); Yebra, J.(17);Suárez, C.(18);Bouhmidi, A.(19);Jurado, R.M.(19);López, A.(20);Algarra, Á.(20);Besó, P.(20);Ponferrada, Á.(21);Plaza, R.(21);Dueñas, C.(22);Benítez, J.M.(23);Soto, P.(23);Castillo, E.(24); Iyo, E.(25);Carbonell-Asíns, J.A.(26);Beltran, B.(27);Mínguez, M.(1);
(1)Hospital Clínico Universitario de Valencia, Digestive Disease Department, Valencia, Spain;(2)Hospital Universitario Ramón y Cajal, Digestive Disease Department, Madrid, Spain;(3)Hospital Universitario Central de Asturias, Digestive Disease Department, Oviedo, Spain;(4)Hospital Universitario Rio Hortega, Digestive Disease Department, Valladolid, Spain;(5)Hospital de Galdakao, Digestive Disease Department, Galdakao, Spain;(6)Hospital Universitario Nuestra Señora de Candelaria, Digestive Disease Department, Sant Cruz de Tenerife, Spain;(7)Hospital Clínic de Barcelona, Digestive Disease Department, Barcelona, Spain;(8)Hospital Provincial de Pontevedra, Digestive Disease Department, Pontevedra, Spain;(9)Hospital de La Princesa, Digestive Disease Department, Madrid, Spain;(10)Hospital Clínico Universitario de Santiago, Digestive Disease Department, Santiago de Compostela, Spain;(11)Hospital Universitario de Cabueñes, Digestive Disease Department, Gijón, Spain;(12)Hospital General de Alicante, Digestive Disease Department, Alicante, Spain;(13)Hospital del Mar, Gastroenterology Department, Barcelona, Spain;(14)Hospital Parc Taulí, Digestive Disease Department, Sabadell, Spain;(15)Hospital General Universitario de Elche, Digestive Disease Department, Elche, Spain;(16)Hospital Universitario Infanta Cristina, Digestive Disease Department, Madrid, Spain;(17)Hospital Universitario de Móstoles, Digestive Disease Department, Móstoles, Spain;(18)Hospital La Paz, Digestive Disease Department, Madrid, Spain;(19)Hospital Santa Bárbara Puertollano, Digestive Disease Department, Puertollano, Spain;(20)Hospital Doctor Peset, Digestive Disease Department, Valencia, Spain;(21)Hospital Universitario Infanta Leonor, Digestive Disease Department, Madrid, Spain;(22)Hospital Universitario de Cáceres, Digestive Disease Department, Cáceres, Spain;(23)Hospital Universitario Reina Sofía de Córdoba, Digestive Disease Department, Córdoba, Spain;(24)Hospital Sant Jaume de Calella, Digestive Disease Department, Calella, Spain;(25)Hospital Comarcal de Inca, Digestive Disease Department, Inca, Spain;(26)INCLIVA Biomedical Research Institute, Bioinformatics and biostatistics Unit, Valencia, Spain;(27)Hospital Universitario y Politécnico La Fe, Digestive Disease Department, Valencia, Spain; On behalf of Young Group of AEG and GETECCU
P607: The Faroese IBD Study: Update on incidence from 2015-2020 and prevalence from 1960-2020ECCO'21 VirtualYear: 2021
Authors: Nielsen, K.R.(1);Midjord, J.(1);Hammer, T.(2);Lophaven, S.(3);Burisch, J.(4);
(1)National Hospital of the Faroe Islands, Department of Medicine, Tórshavn, Faroe Islands;(2)The Faroese Hospital System, Department of Occupational Medicine and Public Health, Tórshavn, Faroe Islands;(3)Omicron Aps, Omicron Aps, Roskilde, Denmark;(4)Hvidovre University Hospital, Gastrounit- Medical section, Hvidovre, Denmark; The Faroese IBD Study
P608: Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCUECCO'21 VirtualYear: 2021
Authors: Zabana Abdo, Y.(1,2);Marín-Jiménez, I.(3);Rodríguez-Lago, I.(4);Ramírez Esteso, F.(5);Meijilde, S.(6);Ramos, L.(7);Gomollón, F.(2,8);Muñoz, F.(9);Suris, G.(10);Ortiz de Zárate, J.(11);Huguet, J.M.(12);Llaó, J.(13);García-Sepulcre, M.(14);Sierra, M.(15);Durà, M.(16);Estrecha, S.(17);Fuentes Coronel, A.(18);Hinojosa, E.(19);Olivan, L.(20);Iglesias, E.(21);Gutiérrez, A.(2,22);Varela, P.(23);Rull, N.(24);Gilabert, P.(25);Hernández-Camba, A.(26);Brotons, A.(27);Ginard, D.(28);Sesé, E.(29);Carpio, D.(30);Aceituno, M.(1,2);Cabriada, J.L.(4);González-Lama, Y.(31);Jiménez, L.(32);Chaparro, M.(2,33);López-San Román, A.(34);Alba, C.(35);Plaza-Santos, R.(36);Piqueras, M.(37);Domènech, E.(2,38);Esteve, M.(1,2);
(1)Hospital Universitari Mútua de Terrassa, Gastroenterology Department- Inflammatory Bowel Disease Unit, Terrassa, Spain;(2)Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREehd, CIBERehd, Madrid, Spain;(3)Hospital Gregorio Marañón, Gastroenterology Department, Madrid, Spain;(4)Hospital de Galdakao, Gastroenterology Department, Bilbao, Spain;(5)Hospital General Universitario de Ciudad Real, Gastroenterology Department, Ciudad Real, Spain;(6)Hospital Universitario de Cruces, Gastroenterology Department, Baracaldo, Spain;(7)Hospital Universitario de Canarias, Gastroenterology Department, Gran Canaria, Spain;(8)Hospital Clínico Universitario 'Lozano Blesa' e IIS Aragón, Gastroenterology Department, Zaragoza, Spain;(9)Hospital Universitario de Salamanca, Gastroenterology Department, Salamanca, Spain;(10)Hospital Universitari de Bellvitge, Gastroenterology Department, L'Hospitalet de Llobregat, Spain;(11)Hospital Universitario de Basurto, Gastroenterology Department, Basurto, Spain;(12)Consorcio Hospital General Universitario de Valencia, Gastroenterology Department, Valencia, Spain;(13)Althaia Xarxa Assistencial Universitària de Manresa, Gastroenterology Department, Manresa, Spain;(14)Hospital Universitario de Elche, Hospital Universitario de Elche, Elche, Spain;(15)Complejo Asistencial Universitario de León, Gastroenterology Department, León, Spain;(16)Hospital Clínico de Valladolid, Gastroenterology Department, Valladolid, Spain;(17)Hospital Universitario Álaba HUA, Gastroenterology Department, Álaba, Spain;(18)Hospital Virgen de la Concha, Gastroenterology Department, Zamora, Spain;(19)Hospital de Manises, Gastroenterology Department, Manises, Spain;(20)Hospital Universitario San Jorge, Gastroenterology Department, Huesca, Spain;(21)Hospital Universitario Reina Sofía de Córdoba e Instituto Maimónides de Investigación Biomédica de Córdoba IMIBIC- Córdoba, Gastroenterology Department, Córdoba, Spain;(22)Hospital General Universitario de Alicante, Gastroenterology, Alicante, Spain;(23)Hospital Universitario de Cabueñes, Gastroenterology Department, Gijón, Spain;(24)Hospital Universitario Son Llàtzer, Gastroenterology Department, Mallorca, Spain;(25)Hospital de Viladecans, Gastroenterology Department, Viladecans, Spain;(26)Hospital Universitario Nuestra Señora de Candelaria, Gastroenterology Department, Santa Cruz de Tenerife, Spain;(27)Hospital Vega Baja de Orihuela, Gastroenterology Department, Orihuela, Spain;(28)Hospital Universitario Son Espases, Gastroenterology Department, Palma de Mallorca, Spain;(29)Hospital Universitari Arnau de Vilanova de Lleida, Gastroenterology Department, Lleida, Spain;(30)Complexo Hospitalario de Pontevedra, Gastroenterology Department, Pontevedra, Spain;(31)Hospital Universitario Puerta de Hierro Majadahonda, Gastroenterology Department, Majadahonda, Spain;(32)Hospital Universitario de Fuenlabrada e Instituto de Investigación Hospital Universitario La Paz IdiPaz, Gastroenterology Department, Madrid, Spain;(33)Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria Princesa IIS-IP, Gastroenterology Department, Madrid, Spain;(34)Hospital Universitario Ramón y Cajal, Gastroenterology Department, Madrid, Spain;(35)Hospital Clínico San Carlos and Instituto de Investigación del Hospital Clínico San Carlos [IdISSC], Gastroenterology Department, Madrid, Spain;(36)Hospital Universitario Infanta Leonor, Gastroenterology Department, Madrid, Spain;(37)Consorci Sanitari de Terrassa, Gastroenterology Department, Terrassa, Spain;(38)Hospital Universitari Germans Trias i Pujol, Gastroenterology Deparment, Badalona, Spain; COVID-19-EII Consortium of the ENEIDA project of GETECCU
